News

Biologicals in EU to be identified by brand names

Published on 2013/05/20

The European Commission has issued a directive which requires biological products to be identified by brand name and not by international nonproprietary name (INN). The European Commission’s Direct...

6 views

Read more →

MEPs adopt directive to give quicker access to generics

Published on 2013/05/17

Members of the European Parliament (MEPs) have adopted the text of the Transparency Directive 2012/0035(COD) by a large majority in a plenary session of the parliament on 6 February 2013. The draft l...

5 views

Read more →

Biosimilars to replace 70% of chemical drugs

Published on 2013/05/15

Biosimilars will replace some 70% of global chemical drugs over the next couple of decades, according to industry experts. This replacement will occur due to the better safety profiles of biosimilars ...

5 views

Read more →

Inequality in Europe over access to biologicals for arthritis

Published on 2013/05/13

Data from a study presented at the European League Against Rheumatism’s Annual European Congress of Rheumatology, EULAR Congress 2012, demonstrates the vast inequalities in access to biologicals for...

5 views

Read more →

Generics policies in Europe have room for improvement

Published on 2013/05/10

In Europe, generics policies have not yet been implemented to their full extent, according to authors Vogler and Zimmerman, reporting on the 2011 Pharmaceutical Pricing and Reimbursement Information (...

10 views

Read more →

Medicines spending in Brazil

Published on 2013/05/08

The Brazilian pharmaceutical market is the third largest in the Americas region, behind the US and Canada; it ranks first in the Latin American region. Pharmaceutical demand will continue to rise, fue...

20 views

Read more →

G-CSF biosimilars – World Marrow Donor Association position

Published on 2013/05/06

The World Marrow Donor Association (WMDA) has expressed its position on the use of granulocyte colony-stimulating factor (G-CSF) biosimilars in healthy donors in an article published in the journal H...

20 views

Read more →

Prescribing in Scotland increases but drug costs drop

Published on 2013/05/03

Spending on medicine in Scotland was 11% less in 2011–2012 compared to spending in 2004–2005. This is despite the volume of prescriptions increasing by 33% during that time, according to a new rep...

11 views

Read more →

Generic Doxil approval may help alleviate drug shortages

Published on 2013/05/01

FDA announced on 4 February 2013 that the agency had approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection). Liposomal doxorubicin is used to tre...

13 views

Read more →

Assessment of biosimilarity under the BPCI Act

Published on 2013/04/29

The Biologics Price Competition and Innovation (BPCI) Act defines a biosimilar as a product that is highly similar to the reference product notwithstanding minor differences in clinically inactive com...

6 views

Read more →

Conflict-of-interest policies reduce brand-name prescribing

Published on 2013/04/26

Psychiatrists who are exposed to conflict-of-interest (COI) policies during their residency are less likely to prescribe brand-name antidepressants after graduation than those who train in residency p...

5 views

Read more →

Biotech firms try to limit biosimilar substitution in US

Published on 2013/04/24

FDA is still to approve a biosimilar and has yet to issue final guidelines outlining the regulatory requirements for approval of a biosimilar in the US. However, despite this fact at least six US sta...

10 views

Read more →